ASSOCIATION OF BETA3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC USE THEREOF

摘要

The invention concerns the association of at least one beta3 adrenergic receptor agonist (or beta3 agonist) with a monoamine reuptake inhibitor. The invention also concerns a pharmaceutical composition comprising the inventive association and its therapeutic use.